Elvia Cowan

SVP, Finance & CAO · Vaxcyte

Elvia Cowan (SVP, Finance & CAO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales, 1 filed past the two-business-day deadline), most often in Vaxcyte, Inc. (PCVX). The largest single filing was $1.6M of PCVX (19,000 sh × $86.74, as filed), executed Oct 5. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells · 1 late

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.7M

shares × price, as filed

Last traded

Nov 2

Filed Nov 4

Median ADV $87.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

PCVX

Vaxcyte, Inc. PCVX · 0 buys · 5 sells 5 filings

Recent filings

PCVXSALE Vaxcyte, Inc. View filing → $147K
2,414 sh × $60.77
Exec Nov 2
Filed Nov 4 · 4:52 PM ET PCVXSALE Vaxcyte, Inc. View filing → $1.6M
19,000 sh × $86.74
Exec Oct 5
Filed Oct 7 · 4:07 PM ET PCVXSALE Vaxcyte, Inc. View filing → $180K
3,000 sh × $60.00
Exec Apr 7
Filed Apr 8 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $146K
2,500 sh × $58.59
Exec Mar 11
Filed Mar 11 · 5:30 PM ET PCVXSALE Vaxcyte, Inc. View filing → $557K
11,623 sh across 2 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET †